MarketLens

Investment Ideas

The FDA Just Killed the Biotech Fast Lane—And Moderna's Stock Is the First Casualty

10 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Is the FDA Poised to Reshape the Peptide Market

Is the FDA Poised to Reshape the Peptide Market

6 months ago

What are the Major Headwinds and Tailwinds Shaping the Biotech Sector in 2026

What are the Major Headwinds and Tailwinds Shaping the Biotech Sector in 2026

8 months ago

What Does the 400 Gbps/lane Breakthrough Mean for Data Centers

What Does the 400 Gbps/lane Breakthrough Mean for Data Centers

6 months ago

What Just Happened with uniQure's Earnings and FDA Update

What Just Happened with uniQure's Earnings and FDA Update

7 months ago

Category

Top Featured Pro Only Stock Analysis Investment Ideas ETFs Crypto

You may also like

Stock News•1 months ago

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Moderna's melanoma vaccine data delivered a much-needed win after years of layoffs and cash burn, potentially reviving its pipeline and investor confidence. The positive readout could strengthen its o...

Stock News•3 months ago

Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout

Moderna fell 11%, while ImmunityBio and Sarepta Therapeutics each dropped 8% in a broad biotech selloff Friday, reversing part of the sector's 2026 rally.

Stock News•3 months ago

Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%.

Moderna rose over 70% in a month after an FDA panel voted 9-0 that its mRNA flu vaccine's benefits outweigh risks. A final approval decision is expected by Aug. 5.

Breaking News

Corporate Earnings

Analyst Ratings

AI Infrastructure

Cybersecurity Threats

Debt/Share Issuance

Earnings Surprise

Geopolitical Tensions

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

2 months ago

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

2 months ago

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

2 months ago

Top Headlines

Stock News•28 minutes ago

Microsoft AI chief says the company beat OpenAI at its own game, using a quarter of the computing power

Stock News•30 minutes ago

Google warns suspected China-linked hackers could exploit BeyondTrust flaw

Stock News•1 hour ago

Tesla's Energy Boss Leaves the Company

Stock News•2 hours ago

Why This Market Washout Will Spark a Year-End Rally

Stock News•2 hours ago

Here Are the 3 Magnificent Seven Stocks I'd Buy Today